Coronavirus spreading graph comparison between countries
Hot Topics
From today:
Covid-19, vaccine, Biden, Johnson, Covid-19 vaccine, President Joe, Analysis, Daunte Wright, who fatally shot, from Afghanistan by, withdraw US troops, & Johnson Covid-19
Articles in topic rare blood
These unlikely events are still more likely than a blood clot after the J&J vaccine
CNN's John Avlon puts into perspective the likelihood of suffering from rare blood clots that have been reported in only six of the 6.8 million Johnson & Johnson Covid-19 vaccine recipients in the US.
[ cnn.com ]Federal official: CDC, FDA taking reports of blood clots and J&J Covid-19 vaccine 'seriously'
US health agencies are taking concerns about blood clots and the Johnson & Johnson Covid-19 vaccine "seriously" and are working to assess whether the shot is associated with a very small increased risk of rare blood clots, a federal official told CNN.
[ cnn.com ]EU agency finds AstraZeneca vaccine can cause rare blood clots
European drug regulators have confirmed a link between the Oxford-AstraZeneca Covid-19 shot and rare blood clots, as UK authorities recommended that people under 30 should take alternative vaccines.
[ cnn.com ]University of Oxford pauses pediatric trial of its vaccine with AstraZeneca, pending review by UK regulator
A pediatric trial of the Oxford-AstraZeneca vaccine has been paused pending a review by the UK's medicines regulator of rare blood clot cases in adults, a University of Oxford spokesperson told CNN Tuesday.
[ cnn.com ]UPDATE 1-Italy's Menarini to buy Stemline Therapeutics in deal valued at up to $677 mln
Privately held Italian drugmaker Menarini Group said on Monday it would buy U.S. company Stemline Therapeutics Inc in a deal valued at up to $677 million, looking to gain access to a U.S. approved drug for a rare blood disease.
[ reuters.com ] companyNews,Girl with rare blood disease inspires others to meet Covid-19 pandemic with hope
Alyssa Jennings knows what it's like to be isolated, sick and self-quarantined. The 11-year-old has a rare blood disease called chronic cyclic neutropenia, which causes her white cell count to drop dramatically low every three months.
[ cnn.com ]UPDATE 1-Alexion to study rare blood-disorder drug in severe COVID-19 patients
Alexion Pharmaceuticals Inc said on Monday it would start a late-stage study of its rare blood-disorder drug, Ultomiris, in COVID-19 patients hospitalized with severe pneumonia or acute respiratory distress syndrome.
[ reuters.com ] companyNews,Alexion to study rare blood-disorder drug in severe COVID-19 patients
Alexion Pharmaceuticals Inc said on Monday it would start a late-stage study of its rare blood-disorder drug, Ultomiris, in COVID-19 patients hospitalized with severe pneumonia or acute respiratory distress syndrome.
[ reuters.com ] companyNews,Celgene's drug for anemia in beta thalassemia priced at $3,441/ 25 mg vial
Celgene Corp's treatment for anemia in patients with beta thalassemia, a rare blood disorder, would be priced at $3,441 for a 25-milligram vial of the drug, partner Acceleron Pharma Inc said.
[ reuters.com ] healthNews,UPDATE 2-Celgene's drug for anemia in beta thalassemia priced at $3,441/ 25 mg vial
Celgene Corp's treatment for anemia in patients with beta thalassemia, a rare blood disorder, would be priced at $3,441 for a 25-milligram vial of the drug, partner Acceleron Pharma Inc said.
[ reuters.com ] companyNews,U.S. FDA approves Celgene's rare blood disorder drug
The U.S. Food and Drug Administration said on Friday it had approved Celgene Corp's treatment for a rare blood disorder.
[ reuters.com ] companyNews,UPDATE 1-FDA approves Alexion's Ultomiris for another rare blood disease
The U.S. Food and Drug Administration on Friday approved Alexion Pharmaceuticals Inc's treatment for a second rare blood disorder, the company said.
[ reuters.com ] companyNews,FDA approves Alexion's Ultomiris for another rare blood disease
The U.S. Food and Drug Administration on Friday approved Alexion Pharmaceuticals Inc's treatment for a second rare blood disorder, the company said.
[ reuters.com ] companyNews,UPDATE 1-Sanofi blood disorder drug wins FDA approval
The U.S. Food and Drug Administration (FDA) said on Wednesday it had approved Sanofi SA's drug to treat a rare blood-clotting disorder in adults in combination with standard-of-care treatments.
[ reuters.com ] companyNews,Sanofi blood disorder drug wins FDA approval
The U.S. Food and Drug Administration (FDA) said on Wednesday it had approved Sanofi SA's drug to treat a rare blood-clotting disorder in adults in combination with standard-of-care treatments.
[ reuters.com ] companyNews,Donors of Rare Blood Type Sought to Save a Miami Toddler
Zainab Mughal, 2, has cancer. Her treatments depend on frequent blood transfusions, but her blood type is extremely rare.
[ nytimes.com ] Blood,UPDATE 2-U.S. FDA approves Stemline Therapeutics' rare blood disease treatment
The U.S. Food and Drug Administration on Friday approved Stemline Therapeutics Inc's Elzonris for the treatment of a rare blood disease in adults and children aged two years and above.
[ reuters.com ] companyNews,Alexion wins early U.S. approval for rare blood disorder drug
The U.S. Food and Drug Administration approved on Friday Alexion Pharmaceuticals Inc's rare blood disorder drug Ultomiris, an early backing that also solidifies the company's dominant market position.
[ reuters.com ] healthNews,UPDATE 2-Alexion wins early U.S. approval for rare blood disorder drug
The U.S. Food and Drug Administration approved on Friday Alexion Pharmaceuticals Inc's rare blood disorder drug Ultomiris, an early backing that also solidifies the company's dominant market position.
[ reuters.com ] companyNews,UPDATE 1-U.S. FDA approves Stemline Therapeutics' rare blood disease treatment
The U.S. Food and Drug Administration on Friday approved Stemline Therapeutics Inc's Elzonris for the treatment of a rare blood disease in adults and children aged two years and above.
[ reuters.com ] companyNews,